Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Alpha Tau Medical Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
DRTS
Nasdaq
8731
https://www.alphatau.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Alpha Tau Medical Ltd
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
- Mar 25th, 2024 12:50 pm
Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update
- Mar 7th, 2024 9:01 pm
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference
- Feb 26th, 2024 1:30 pm
Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans
- Feb 23rd, 2024 1:46 pm
Alpha Tau Medical Ltd. (NASDAQ:DRTS) most popular amongst retail investors who own 58%, insiders hold 22%
- Jan 13th, 2024 1:47 pm
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Dec 20th, 2023 2:15 pm
Sidoti Events, LLC's Virtual December Small-Cap Conference
- Dec 5th, 2023 3:25 pm
Alpha Tau to Participate in Sidoti Small-Cap Conference
- Nov 29th, 2023 1:30 pm
Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer
- Nov 28th, 2023 1:30 pm
Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer
- Nov 20th, 2023 1:30 pm
Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- Nov 16th, 2023 9:30 pm
Alpha Tau to Participate in November Investor Conferences
- Nov 1st, 2023 12:30 pm
Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now
- Nov 1st, 2023 11:00 am
Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility
- Oct 30th, 2023 12:30 pm
Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board
- Oct 24th, 2023 1:00 pm
Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now
- Oct 3rd, 2023 11:00 am
Here's Why We're Not Too Worried About Alpha Tau Medical's (NASDAQ:DRTS) Cash Burn Situation
- Sep 16th, 2023 1:28 pm
Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical Center
- Sep 14th, 2023 12:30 pm
Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update
- Aug 28th, 2023 8:02 pm
Alpha Tau Medical to Participate in September Investor Conferences
- Aug 24th, 2023 12:00 pm
Scroll